Oral delivery of infliximab via self-assembled nano-in-microspheres for enhanced inflammatory bowel disease therapy

Key Points

• Using nano-in-microspheres enhances the delivery of infliximab to treat inflammatory bowel disease effectively.
• A notable increase in bioavailability was observed, achieving up to 70% compared to traditional methods.
• The method utilized self-assembled nano-in-microsphere technology to improve drug retention and absorption.
• Such advancements may lead to more effective therapies for patients with inflammatory bowel disease.